RGAEX | VSPGX | RGAEX / VSPGX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 23 years | 6 years | - |
Gain YTD | 33.899 | 40.314 | 84% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 313B | 14.4B | 2,174% |
Annual Yield % from dividends | 0.44 | 0.89 | 49% |
Returns for 1 year | 35.26 | 40.28 | 88% |
Returns for 3 years | 18.49 | 29.74 | 62% |
Returns for 5 years | 55.53 | 119.94 | 46% |
Returns for 10 years | 97.09 | 307.38 | 32% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FTXH | 27.50 | 0.24 | +0.87% |
First Trust Nasdaq Pharmaceuticals ETF | |||
FXE | 96.84 | -0.16 | -0.16% |
Invesco CurrencyShares® Euro Currency | |||
QQMG | 36.36 | -0.16 | -0.44% |
Invesco ESG NASDAQ 100 ETF | |||
PRF | 41.38 | -0.27 | -0.65% |
Invesco FTSE RAFI US 1000 ETF | |||
CDC | 63.17 | -0.43 | -0.68% |
VictoryShares US EQ Inc Enh Vol Wtd ETF |